Philippe Thompson-Leduc
 
                    Education
M.Sc., epidemiology, Laval University; B.Sc., biology, Concordia University
Summary of Experience
Mr. Thompson-Leduc is an epidemiologist specializing in pharmacoepidemiology and health economics and outcomes research (HEOR). He has conducted numerous health-related studies, including medical chart review studies (both site-based and physician panel-based), systematic reviews, meta-analyses, and commercial claims database analyses. His work spans a variety of disease areas, including autoimmune diseases, endocrinology, infectious diseases, primary care, and oncology. He has presented his research at numerous international conferences and is the author of several peer-reviewed scientific articles in publications such as the Journal of Medical Economics, Critical Care Medicine, Academic Medicine, and BMJ Open. Prior to joining Analysis Group, Mr. Thompson-Leduc worked as a student researcher at the Canada Research Chair in Implementation of Shared Decision Making in Primary Care at Laval University in Quebec City. His research focused on knowledge transfer and patient engagement in shared health care decision making.
- 
                                                        Development and validation of a claims-based algorithm to identify moderate exacerbations in patients with asthma treated in the USRespiratory Medicine, 2024 
 2024Roberts MH, Duh MS, Rothnie KJ, Zhang S, Czira A, Slade D, Cheng WY, Thompson-Leduc P, Greatsinger A, Zhang A, Mapel D 
- 
                                                        Frequency and economic burden of exacerbations in inhaled corticosteroid/long-acting beta-agonist-treated patients with asthma: A retrospective US claims studyRespiratory Medicine, 2024 
 2024Duh MS, Roberts MH, Rothnie KJ, Cheng WY, Thompson-Leduc P, Zhang S, Czira A, Slade D, Greatsinger A, Zhang A, Mapel D 
- 
                                                        Herpes zoster burden in patients with asthma: real-world incidence, healthcare resource utilisation and costBMJ Open Respiratory Research, 2024 
 2024Singer D, Thompson-Leduc P, Ma S, Gupta D, Cheng WY, Muthukumar A, Devine F, Sundar M, Bogart M, Hagopian E, Poston S, Duh MS, Oppenheimer JJ 
- 
                                                        Burden of Herpes Zoster Among Patients with Psoriatic Arthritis in the United StatesPsoriasis: Targets and Therapy, 2024 
 2024Singer D, Thompson-Leduc P, Ma S, Gupta D, Cheng WY, Sendhil SR, Sundar M, Hagopian E, Stempniewicz N, Duh MS, Poston S 
- 
                                                        Clinical and Economic Burden of Herpes Zoster in Patients with Rheumatoid Arthritis: A Retrospective Cohort Study Using Administrative ClaimsRheumatology and Therapy, 2023 
 2023Singer D, Thompson-Leduc P, Poston S, Gupta D, Cheng WY, Ma S, Devine F, Enrique A, Duh MS, Curtis JR 
- 
                                                        Incidence and Risk of Herpes Zoster in Patients with Ulcerative Colitis and Crohn's Disease in the USAGastroenterology Report, 2023 
 2023Singer D, Thompson-Leduc P, Gupta D, Cheng WY, Poston S, Ma S, Pawlowski JE, Duh MS, Morris ED, Devine F, Farraye FA 
- 
                                                        Incidence of Herpes Zoster in Patients with Rheumatoid Arthritis in the United States: A Retrospective Cohort StudyJournal of Rheumatology, 2023 
 2023Singer D, Thompson-Leduc P, Poston S, Gupta D, Cheng WY, Ma S, Devine F, Duh MS, Curtis JR 
- 
                                                        Economic and Clinical Burden of Herpes Zoster Among Patients With Inflammatory Bowel Disease in the United StatesCrohn's & Colitis 360, 2023 
 2023Singer D, Thompson-Leduc P, Gupta D, Poston S, Cheng WY, Ma S, Pawlowski JE, Duh MS, Devine F, Banatwala A, Bernstein E, Farraye FA 
- 
                                                        Burden of Herpes Zoster Among Patients with Psoriasis in the United StatesDermatology and Therapy, 2023 
 2023Singer D, Thompson-Leduc P, Ma S, Gupta D, Cheng WY, Sendhil SR, Sundar M, Hagopian E, Stempniewicz N, Duh MS, Poston S 
- 
                                                        Progression-Free Survival of Daratumumab Versus Bortezomib Triplet Combination With Lenalidomide and Dexamethasone in Transplant Ineligible Patients With Newly Diagnosed Multiple Myeloma: TAURUS Chart Review StudyClinical Lymphoma, Myeloma & Leukemia, 2023 
 2023Gordan LN, Tan CR, Vescio R, Ye JC, Schinke C, Medhekar R, Fu AZ, Lafeuille MH, Thompson-Leduc P, Khare V, Reitan J, Milkovich G, Kaila S, Davies F, Usmani SZ 
- 
                                                        Long-Term Effectiveness and Safety of Dutasteride versus Finasteride in Patients with Male Androgenic Alopecia in South Korea: A Multicentre Chart Review StudyAnnals of Dermatology, 2022 
 2022Choi GS, Sim WY, Kang H, Huh CH, Lee YW, Shantakumar S, Ho YF, Oh EJ, Duh MS, Cheng WY, Bobbili P, Thompson-Leduc P, Ong G 
- 
                                                        Assessment of the Impact of a Meningitis/Encephalitis Panel on Hospital Length of Stay: A Systematic Review and Meta-AnalysisAntibiotics, 2022 
 2022Hueth KD, Thompson-Leduc P, Totev TI, Milbers K, Timbrook TT, Kirson N, Hasbun R 
- 
                                                        Patient characteristics, treatment patterns, and outcomes among black and white patients with multiple myeloma initiating daratumumab: A real-world chart review studyClinical Lymphoma, Myeloma & Leukemia, 2022 
 2022Atrash S, Thompson-Leduc P, Tai MH, Kaila S, Gray K, Ghelerter I, Lafeuille MH, Jayabalan D, Lefebvre P, Rossi A 
- 
                                                        Evaluation of treatment patterns, healthcare resource utilization, and costs among patients receiving treatment for cytomegalovirus following allogeneic hematopoietic cell or solid organ transplantationJournal of Medical Economics, 2022 
 2022Cheng WY, Avery RK, Thompson-Leduc P, Cheung HC, Bo T, Duh MS, Hirji I 
- 
                                                        Chronic Obstructive Pulmonary Disease Is Associated with an Increased Risk of Herpes Zoster: A Retrospective United States Claims Database AnalysisThe Clinical Respiratory Journal, 2022 
 2022Thompson-Leduc P, Ghaswalla P, Cheng WY, Wang MJ, Bogart M, Patterson BJ, Duh MS, Park S, Yawn BP 
- 
                                                        Outcomes and resource use of patients with large hemispheric infarction and cerebral edema: analysis of real-world dataCurrent Medical Research and Opinion, 2021 
 2021Chen SY, Thompson-Leduc P, Sawyer Jr RN, Fakih I, Cheung HC, Macheca M, Kirson NY, Torbey M 
- 
                                                        Development and Validation of a Healthcare Utilization-Based Algorithm to Identify Acute Exacerbations of Chronic Obstructive Pulmonary DiseaseInternational Journal of Chronic Obstructive Pulmonary Disease, 2021 
 2021Mapel DW, Roberts MH, Sama S, Bobbili PJ, Cheng WY, Duh MS, Nguyen C, Thompson-Leduc P, Van Dyke MK, Rothnie KJ, Sundaresan D, Certa JM, Whiting TS, Brown JL, Roblin DW 
- 
                                                        Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States: A Systematic Review and Meta-AnalysisCNS Drugs, 2021 
 2021Lin D, Thompson-Leduc P, Ghelerter I, Nguyen H, Lafeuille MH, Benson C, Mavros P, Lefebvre P 
- 
                                                        Increased Health Care Resource Utilization and Costs Associated with Herpes Zoster Among Patients Aged ≥50 Years with Chronic Obstructive Pulmonary Disease in the United StatesChronic Obstructive Pulmonary Diseases, 2021 
 2021Ghaswalla P, Thompson-Leduc P, Cheng WY, Kunzweiler C, Wang M, Bogart M, Patterson BJ, Duh MS, Wojciehowski J, Park S, Yawn BP 
- 
                                                        Decreased antibiotic exposure using a procalcitonin protocol for respiratory infections and sepsis in US community hospitals (ProCommunity)Current Medical Research and Opinion, 2021 
 2021DeSear KE, Thompson-Leduc P, Van Schooneveld TC, Kirson N, Chritton JJ, Ie S, Cheung HC, Ou S, Zimmer L, Schuetz P 
- 
                                                        Treatment patterns and effectiveness of patients with multiple myeloma initiating Daratumumab across different lines of therapy: a real-world chart review studyBMC Cancer, 2021 
 2021Atrash S, Thompson-Leduc P, Tai MH, Kaila S, Gray K, Ghelerter I, Lafeuille MH, Lefebvre P, Rossi A 
- 
                                                        Association between biochemical control and comorbidities in patients with acromegaly: an Italian longitudinal retrospective chart review studyJournal of Endocrinological Investigation, 2020 
 2020Colao A, Grasso LFS , Di Cera M, Thompson-Leduc P, Cheng WY, Cheung HC, Duh MS, Neary MP, Pedroncelli AM, Maamari R, Pivonello R 
- 
                                                        ProCommunity: procalcitonin use in real-world US community hospital settingsCurrent Medical Research and Opinion, 2020 
 2020DeSear KE, Thompson-Leduc P, Kirson N, Chritton JJ, Ie S, Van Schooneveld TC, Cheung HC, Ou S, Schuetz P 
- 
                                                        Real-world treatment patterns among patients with advanced gastric cancer in Russia: a chart review studyJournal of Drug Assessment, 2019 
 2019Tjulandin SA, Tryakin AA, Besova NS, Sholokhova E, Ivanova JI, Cheng WY, Schmerold LM, Thompson-Leduc P, Novick D 
- 
                                                        Economic and quality of life burden of anemia on patients with CKD on dialysis: a systematic reviewJournal of Medical Economics, 2019 
 2019Spinowitz B, Pecoits-Filho R, Winkelmayer WC, Pergola PE, Rochette S, Thompson-Leduc P, Lefebvre P, Shafai G, Bozas A, Sanon M, Krasa HB 
- 
                                                        Economic Burden and Health-Related Quality of Life Associated with Current Treatments for Anaemia in Patients with CKD not on Dialysis: A Systematic ReviewPharmacoEconomics - Open, 2019 
 2019Pergola PE, Pecoits-Filho R, Winkelmayer WC, Spinowitz B, Rochette S, Thompson-Leduc P, Lefebvre P, Shafai G, Bozas A, Sanon M, Krasa HB 
- 
                                                        Mild traumatic brain injury in the United States: demographics, brain imaging procedures, health-care utilization and costsBrain Injury, 2019 
 2019Pavlov V, Thompson-Leduc P, Zimmer L, Wen J, Shea J, Beyhaghi H, Toback S, Kirson N, Miller M 
- 
                                                        Comorbidities and Survival in Patients With Lipodystrophy: An International Chart Review StudyThe Journal of Clinical Endocrinology and Metabolism, 2019 
 2019Akinci B, Oral EA, Neidert A, Rus D, Cheng WY, Thompson-Leduc P, Cheung HC, Bradt P, de Freitas MCF, Montenegro RM, Fernandes VO, Cochran E, Brown RJ 
- 
                                                        Procalcitonin guidance in patients with lower respiratory tract infections: a systematic review and meta-analysisClinical Chemistry and Laboratory Medicine. May 1 2018 
 2018Hey J, Thompson-Leduc P, Kirson NY, Zimmer L, Wilkins D, Rice B, Iankova I, Krause A, Schonfeld SA, DeBrase CR, Bozzette S, Schuetz P 
- 
                                                        Efficacy and Safety of Procalcitonin Guidance in Patients With Suspected or Confirmed Sepsis: A Systematic Review and Meta-AnalysisCritical Care Medicine. Dec 21 2017 
 2017Iankova I, Thompson-Leduc P, Kirson NY, Rice B, Hey J, Krause A, Schonfeld SA, DeBrase CR, Bozzette S, Schuetz P 
- 
                                                        Adherence, persistence, and inpatient utilization among adult schizophrenia patients using once-monthly versus twice-monthly long-acting atypical antipsychoticsJournal of Medical Economics. Feb 2018; 21(2):135-143 
 2017Pilon D, Alcusky M, Xiao Y, Thompson-Leduc P, Lafeuille MH, Lefebvre P, Benson C 
- 
                                                    April 11, 2024
- 
                                                    December 1, 2023
- 
                                                    March 29, 2022
- 
                                                    June 4, 2021
